PHT Corporation Promotes Nick Randazzo to Vice President of Sales
Global ePRO market leader expands leadership role of 10-year ePRO industry veteran
BOSTON, Mass. – February 17, 2010 – PHT Corporation, the leading provider of ePRO (electronic patient reported outcome) solutions used in more than 400 clinical trials worldwide, announced the promotion of Nick Randazzo to Vice President of Sales, reporting to PHT President and CEO Phil Lee.
Mr. Randazzo joined PHT in 2000 and was the company’s leading account executive for several years, helping to grow revenues and develop flagship accounts. In 2005, Mr. Randazzo took on a leadership role within the PHT sales organization which rapidly included management of the entire global sales team.
PHT’s President and CEO Phil Lee said, “Nick has an unsurpassed knowledge of how biopharmaceutical companies can adopt ePRO to conduct safer, smaller and more economical clinical trials. His integrity, professionalism and high ethical conduct have earned the respect of our customers and colleagues, and set the standard for how a sales organization should function.”
Mr. Randazzo said, “My charter is to maintain PHT’s strength with our core customers and therapies as we expand our success into new therapeutic areas and organizations. We’ll continue our ambitious worldwide growth strategy to help more and more trial sponsors effectively capture the voice of patients in clinical research by moving from outdated paper diaries to ePRO for clinical trials.”
Prior to joining PHT, Mr. Randazzo was a top performer in sales positions at Wyeth and CR Bard Mr. Randazzo holds a BA from the University of Connecticut.
About PHT Corporation
PHT is the market-leading provider of electronic patient reported outcome (ePRO) solutions that have been used in more than 400 clinical trials by over 100 biopharmaceutical clients. Its proven LogPad® System and versatile SitePad® Tablet deliver the voice of the patient, in 88 languages, from homes and sites in 65 countries around the world. By capturing high-quality and time-stamped assessments with minimal respondent burden, trial sponsors are able to run smaller and more conclusive clinical research programs resulting in significant R&D cost savings. Real-time study management through PHT StudyWorks™ features eClinical data integration, standard and custom data summaries for compliance and enrollment, SafetyPRO™ email alerts, and the industry’s premier study archive. Patient experiences captured firsthand by PHT’s ePRO Product Suite have been used successfully in at least 12 NDA submissions and eight approvals to date. For more information, review the interactive product demonstrations at PHT’s award-winning www.phtcorp.com site.
PHT, LogPad, eSense, StudyWorks, SafetyPRO and SitePad are among the registered trademarks and trademarks of PHT Corporation.
Contact: Brenda Nashawaty, bnashawaty@phtcorp.com, 617-688-3253
###
